Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer (Q38198735)

30 August 2017

title

Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer (English)

1 reference

30 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24661020%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Eyad Elkord

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24661020%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

May Abd Al Samid

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24661020%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Basel K al-Ramadi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24661020%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

language of work or name

English

0 references

publication date

24 March 2014

1 reference

Expert Opinion on Biological Therapy

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24661020%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24661020%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24661020%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

931-945

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24661020%20AND%20SRC:MED&resulttype=core&format=json

Regulatory T cells and immune tolerance

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Natural and induced T regulatory cells in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

T regulatory cells in cancer: recent advances and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Transient Foxp3(+) regulatory T-cell depletion enhances therapeutic anticancer vaccination targeting the immune-stimulatory properties of NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Regulatory T cells: recommendations to simplify the nomenclature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Peripherally induced tregs - role in immune homeostasis and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Regulatory T cells: how do they suppress immune responses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Neuropilin 1: function and therapeutic potential in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Expression of neuropilin-1 on in vivo induced regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Making sense of latent TGFbeta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CD39 is highly involved in mediating the suppression activity of tumor-infiltrating CD8+ T regulatory lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CD39 and control of cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CD26: a negative selection marker for human Treg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

The CD4+CD26- T-cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T-cell profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Tim-3 expression defines regulatory T cells in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Regulatory T-cell Trafficking: From Thymic Development to Tumor-Induced Immune Suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Phenotypical and functional specialization of FOXP3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

FOXP3 controls regulatory T cell function through cooperation with NFAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Genome-wide DNA methylation analysis identifies hypomethylated genes regulated by FOXP3 in human regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Epigenetic control of the foxp3 locus in regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

FOXP3 expression in tumor cells and implications for cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1β by downregulating their suppressor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Helios marks strongly autoreactive CD4+ T cells in two major waves of thymic deletion distinguished by induction of PD-1 or NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

FOXP3 and FOXP3-regulated microRNAs suppress SATB1 in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

SATB1 targets chromatin remodelling to regulate genes over long distances

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

In vivo-activated CD103+ Foxp3+ Tregs: of men and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Differences in tumor regulatory T-cell localization and activation status impact patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Prognostic impact of FoxP3+ regulatory T cells in relation to CD8+ T lymphocyte density in human colon carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Functional plasticity of antigen-specific regulatory T cells in context of tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Adenosine and prostaglandin e2 production by human inducible regulatory T cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Phenotypic and functional characteristic of a newly identified CD8+ Foxp3- CD103+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Phenotypic and functional characterization of CD8(+) T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

In vivo dynamical interactions between CD4 Tregs, CD8 Tregs and CD4+ CD25- cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Denileukin diftitox (ONTAK) induces a tolerogenic phenotype in dendritic cells and stimulates survival of resting Treg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Clinical Development of the Anti–CTLA-4 Antibody Tremelimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

New checkpoint inhibitors ride the immunotherapy tsunami.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

The PDL1-PD1 axis converts human TH1 cells into regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Role of LAG-3 in regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

A soluble form of lymphocyte activation gene-3 (IMP321) induces activation of a large range of human effector cytotoxic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

A phase I pharmacokinetic and biological correlative study of IMP321, a novel MHC class II agonist, in patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Nivolumab plus ipilimumab in advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Intratumoral FOXP3+VEGFR2+ regulatory T cells are predictive markers for recurrence and survival in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Association of circulating regulatory T cell number with the incidence and prognosis of diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CD49d provides access to "untouched" human Foxp3+ Treg free of contaminating effector cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Helios expression is a marker of T cell activation and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Novel Foxo1-dependent transcriptional programs control T(reg) cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Inhibition of p300 impairs Foxp3⁺ T regulatory cell function and promotes antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Identification of human regulatory T cells in the setting of T-cell activation and anti-CTLA-4 immunotherapy on the basis of expression of latency-associated peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2014.900539

10.1517/14712598.2014.900539

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24661020%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference